Loading...
Loading...
Predicts the risk of right heart failure (RHF) requiring right ventricular assist device (RVAD) or sustained inotropes for > 14 days after left ventricular assist device (LVAD) implantation. Developed from the European Registry for Patients with Mechanical Circulatory Support (EUROMACS).
Severe Tricuspid Regurgitation (Grade 3–4 on Echo)
CVP/PCWP Ratio > 0.63 (or RAP/PCWP > 0.54)
Non-Elective LVAD Implantation (INTERMACS Profile 1–2)
BMI > 25 kg/m²
Prior Cardiac Surgery
Awaiting input
Fill in the parameters to see your result